Pressure ulcer management in the geriatric patient

Annals of Pharmacotherapy

Volumn 32, Issue 11, 1998, Pages 1221-1227

  Orlando, Patricia L ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

Decubitus ulcers; Geriatrics; Pressure ulcers

Indexed keywords

ANTIBIOTIC AGENT; BACITRACIN; COLLAGENASE; ELASE; EPIDERMAL GROWTH FACTOR; GLYCERYL TRINITRATE; GRANULEX; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; GROWTH FACTOR; KERATINOCYTE GROWTH FACTOR; NEOMYCIN; PANAFIL; PAPAIN; PHENYTOIN; PLATELET DERIVED GROWTH FACTOR; POLYMYXIN; PSEUDOMONIC ACID; SOMATOMEDIN; SULFADIAZINE SILVER; SUTILAIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRYPSIN; UNCLASSIFIED DRUG;

ANTIBIOTIC THERAPY; DEBRIDEMENT; DECUBITUS; GERIATRIC CARE; GERIATRIC PATIENT; HIGH RISK PATIENT; PATIENT EDUCATION; PRIORITY JOURNAL; REVIEW; TREATMENT PLANNING; WOUND CARE; WOUND HEALING;

EID: 0031756398     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.16482     Document Type: Review

References (59)

1. Vohra RK, McCollum CN. Pressure sores. Br Med J 1994;309:853-7.
2. National Pressure Ulcer Advisory Panel. Pressure ulcers prevalence, cost and risk assessment: consensus development conference statement. Decubitus 1989;2:24-8.
3. Characteristics of nursing home residents, health status, and care received: national nursing home survey, United States, May-December 1977. Hyattsville, MD: National Center for Health Statistics, 1981. US Department of Health and Human Services publication PHS 81-1712.
4. Versluysen JF. Pressure sores in elderly patients: the epidemiology related to hip operations. J Bone Joint Surg 1985;67:10-3.
5. Hibbs P. The economics of pressure ulcer prevention. Decubitus 1988;1: 32-8.
6. Longe RL. Current concepts in clinical therapeutics: pressure sores. Clin Pharm 1986;5:669-81.
7. Gilchrist BA, ed. Age-associated changes in normal skin. In: Skin and aging processes. Boca Raton, FL: CRC Press, Inc., 1984:17-35.
8. Leigh IH, Bennet G. Pressure ulcers: prevalence, etiology, and treatment modalities. Am J Surg 1994;167(suppl):25S-30S.
9. Frater-Schroder M, Risau W, Hallmann R, Gautschi P. Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vivo, is angiogenic in vivo. Proc Natl Acad Sci U S A 1987;84:5277-81.
10. Fishel RS, Barbul A, Beschorner WE, Wasserkrug HL, Efron G. Lymphocyte participation in wound healing. Morphologic assessment using monoclonal antibodies. Ann Surg 1987;206:25-9.
11. Barbul A. Immune aspects of wound repair. Clin Plast Surg 1990;17: 433-42.
12. Schroeder D, Gillanders L, Mahr K. Effects of immediate postoperative enteral nutrition on body composition, muscle function, and wound healing. JPEN J Parenter Enteral Nutr 1991;15:376-83.
13. Thomas DR. The role of nutrition in prevention and healing of pressure ulcers. Clin Geriatr Med 1997;13:497-511.
14. Hunter T, Rajan KT. The role of ascorbic acid in the pathogenesis and treatment of pressure sores. Paraplegia 1971;8:211-5.
15. Krouskop TA, Reddy NP, Spencer WA, Secor JW. Mechanisms of decubitus ulcer formation: a hypothesis. Med Hypotheses 1978;4:37-9.
16. Panel on the Prediction and Prevention of Pressure Ulcers in Adults. Pressure ulcers in adults: prediction and prevention. Quick reference guide for clinicians. AHCPR publication no. 92-0050. Rockville, MD: Agency for Health Care Policy and Research, Public Health Service, US Department of Health and Human Services, May 1992.
17. Allman RD. Pressure ulcers among the elderly. N Engl J Med 1989;320: 850-3.
18. Evans JM, Andrews KL, Chutka DS, Fleming KC, Gamess SL. Pressure ulcers: prevention and management. Mayo Clin Proc 1995;70:789-99.
19. Clark M, Rowland LB. Preventing pressure sores: matching patient and mattress using interface pressure measurements. Decubitus 1989;2:34-9.
20. Ryan DW. The fluidised bed. Intensive Care Med 1995;21:270-6.
21. Goode PS, Thomas DR. Pressure ulcers: local wound care. Clin Geriatr Med 1997;13:543-52.
22. Patterson JA, Bennett RG. Prevention and treatment of pressure sores. J Am Geriatr Soc 1995;43:919-27.
23. Jeter KF, Tintle TE. Wound dressings of the nineties: indications and contraindications. Clin Podiatr Med Surg 1991;8:799-816.
24. Robson MC, Duke WF, Krizek TJ. Rapid bacterial screening in the treatment of civilian wounds. J Surg Res 1973;14:420-30.
25. Gilchrist B, Reed C. The bacteriology of chronic venous ulcers treated with occlusive hydrocolloid dressing. Br J Dermatol 1988;121:337-44.
26. Bryan CS, Dew CE, Reynolds KL. Bacteremia associated with decubitus ulcers. Arch Intern Med 1983;143:2093-5.
27. Sugarman B, Hawes S, Musher DM, Klima M, Young EJ, Pircher F. Osteomyelitis beneath pressure sores. Arch Intern Med 1983;143:683-8.
28. Perry CR, Pearson RL, Miller GA. Accuracy of cultures of material from swabbing of the superficial aspect of the wound and needle biopsy in the preoperative assessment of osteomyelitis. J Bone Joint Surg 1991;73(A) (suppl):745-9.
29. Witkowski JA, Parish LC. Debridement of cutaneous ulcers: medical and surgical aspects. Clin Dermatol 1992;9:585-91.
30. PierLeoni EE. Topical metronidazole therapy for infected decubitus ulcers. J Am Geriatr Soc 1984;32:775.
31. Wheeland RG, Gilchrist RW, Young CJ. Treatment of ischemic digital ulcers with nitroglycerin ointment. J Dermatol Surg Oncol 1983;9:548-51.
32. Gorfine SR. Topical nitroglycerin therapy for anal fissures and ulcers. N Engl J Med 1995;333:1156-7.
33. Rinieri J. Apport de la trinitrine percutanee dans le traitement des ulceres rebelles. Phlebologie 1987;40:955-8.
34. Romanelli M, Katz MH, Alvarez AF, Eaglstein WH, Falanga V. The effect of topical nitroglycerin on transcutaneous oxygen. Br J Dermatol 1991;124:354-7.
35. Anstead GM, Hart LM, Sunahara JF, Liter ME. Phenytoin in wound healing. Ann Pharmacother 1996;30:768-75.
36. Lewis WG, Rhodes RS. Systemic absorption of topical phenytoin sodium (letter). Ann Pharmacother 1994;28:961.
37. Steed DL. The role of growth factors in wound healing. Surg Clin North Am 1997;77:575-86.
38. Brown GL, Nanney LB, Griffen J, Cramer AB, Yancey JM, Curtsinger LJ, et al. Enhancement of wound healing by topical treatment with epidermal growth factor. N Engl J Med 1989;321:76-9.
39. Hennessey PJ, Black T, Andrassy RJ. Epidermal growth factor and insulin act synergistically during diabetic healing. Arch Surg 1990;125: 926-9.
40. Hata R, Hori H, Nagai Y, Tanaka S, Kondo M, Hiramatsu M, et al. Selective inhibition of type I collagen synthesis in osteoblastic cells by epidermal growth factor. Endocrinology 1984;115:867-76.
41. Pierce GF, Mostoe TA, Lingelbach J, Masakowski VR, Griffin GL, Senior RM, et al. Platelet-derived growth factor and transforming growth factor-beta enhance tissue repair activities by unique mechanisms. J Cell Biol 1989;109:429-40.
42. Robson MC, Phillips LG, Thomason A, Robson LE, Pierce GF. Platelet-derived growth factor-BB in chronic pressure ulcers. Lancet 1992;339: 23-5.
43. Mustoe TA, Cutler NR, Allman RM, Goode PS, Deuel TF, Prause JA, et al. A Phase II study to evaluate recombinant PDGF-BB in the treatment of stage III/IV pressure ulcers. Arch Surg 1994;129:213-9.
44. Steed DL. The diabetic ulcer study group. Clinical evaluation of recombinant human platelet-derived growth factor (rhPDGF-BB) for the treatment of lower extremity diabetic ulcers. J Vasc Surg 1995;18:139-46.
45. Ignotz RA, Massague J. Transforming growth factor-B stimulates the expression of fibronectin and collagen and their incorporation in the extracellular matrix. J Biol Chem 1986;261:4337-45.
46. Quaglino D Jr, Nanney LB, Kennedy R, Davidson JM. Transforming growth factor B stimulates wound healing and modulates extracellular matrix gene expression in pig skin. Lab Invest 1990;63:307-19.
47. Pierce GF, Tarpley J, Yanagihara D, Mustoe TA, Fox GM, Thomason A. PDGF-BB, TGF-B1, and basic FGF in dermal wound healing: neovessel and matrix formation and cessation of repair. Am J Pathol 1992; 140:1375-88.
48. Robson MC, Phillips LG, Lawrence WT, Bishop JB, Youngerman JS, Hayward PG, et al. The safety and effect of topically applied recombinant basic fibroblast growth factor on the healing of chronic pressure sores. Ann Surg 1992;216:401-8.
49. Jyung RW, Mustoe TA, Busby WH, Clemmons DR. Increased woundbreaking strength induced by insulin-like growth factor-1 in combination with IGF-binding protein-1. Surgery 1994;115:233-9.
50. Herndon DN, Barrow RE, Kunkel KR, Broemelinig L, Rutan RL. Effects of recombinant human growth hormone on donor-site healing in severely burned children. Ann Surg 1990;212:424-31.
51. Pierce GF, Yanagihara D, Klopchin K, Danilenko DM, Hsu E, Kenney WC, et al. Stimulation of all epithelial elements during skin regeneration by keratinocyte growth factor. J Exp Med 1994;179:831-40.
52. Peters KG, DeVries C, Williams LT. Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc Natl Acad Sci U S A 1993;90:8915-9.
53. Jyung R, Wu L, Pierce GF, Mustoe TA. Granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor: differential action on incisional wound healing. Surgery 1994;115:325-34.
54. DeCunzo LP, MacKenzie JW, Marafmo BJ, Devereux DF. The effect of interleukin-2 administration on wound healing in adriamycin-treated rats. J Surg Res 1990;49:419-27.
55. Kucukcelebi A, Hui PS, Sahara K, Ko F, Robson MC. The effect of interleukin-1B on the inhibition of contraction of excisional wounds caused by bacterial contamination. Surg Forum 1992;43:715-6.
56. Brown RL, Breeden MP, Greenhalgh DG. PDGF and TGF-alpha act synergistically to improve wound healing in the genetically diabetic mouse. J Surg Res 1994;56:562-70.
57. Colvin C. Topical agents for pressure sores. In: Gelman CR, Rumack BH, Hutchison TA, eds. Drugdex(R) system. Englewood, CO: Micromedex, Inc. (edition expired 3/98).
58. Barnes SH. Patient/family education for the patient with a pressure necrosis. Nurs Clin North Am 1987;22:463-74.
59. Moody BL, Fanale JE, Thompson M, Vaillancourt D, Symonds G, Bonasoro C. Impact of staff education on pressure sore development in elderly hospitalized patients. Arch Intern Med 1988;148:2241-3.